RESUMEN
Leptospirosis is a zoonotic disease caused by spirochetal bacterial of the genus Leptospira affecting virtually all mammals. The infection has a broad range of effects, from mild clinical manifestation to multiple organ failure, and ultimately death. A 5-months-old male unvaccinated dog was admitted to the University Veterinary Teaching Hospital presenting dullness, dehydration, jaundiced mucous, bloody diarrhea, vomiting, and hyporexia. Microscopic agglutination test (MAT) detected serological titers of 1:1.600 for serogroup Canicola. After five days of monitoring by the medical team he developed fever and swelling of carpal and tarsal joints, accompanied by functional limitation. Initial antimicrobial treatment was instituted for leptospirosis. Polyarthritis responsiveness to glucocorticoid therapy was observed through decreasing signs of inflammation of the affected joints. The diagnosis of leptospirosis was further confirmed by molecular investigation for Leptospira spp. on blood and synovial fluid samples. Amplification and sequencing of the secY partial gene characterized the infective bacterial as Leptospira interrogans. From the 7th day the respiratory condition worsened and on Day 14 the patient evolved to death, when necropsy and histological evaluation were performed. Prominent anatomopathological findings included: fibrinous polyarthritis, bronchointerstitial pneumonia, intense hepatocyte dissociation, cholestasis, and periportal multifocal hepatitis, diffuse acute tubular necrosis, and significant dystrophic mineralization in the renal parenchyma, lungs, and atrial endocardium. Here, we present a case report of systemic clinical manifestations polyarthritis associated with the presence of leptospiras in the synovial fluid. We highlight the need for richer knowledge about the different clinical manifestations of leptospirosis.
Asunto(s)
Artritis/veterinaria , Enfermedades de los Perros/diagnóstico , Síndrome Hepatorrenal/veterinaria , Leptospira interrogans , Leptospirosis/veterinaria , Pruebas de Aglutinación/veterinaria , Animales , Antibacterianos , Anticuerpos Antibacterianos/sangre , Artritis/microbiología , Enfermedades de los Perros/microbiología , Perros , Fiebre/veterinaria , Síndrome Hepatorrenal/microbiología , Leptospira interrogans/clasificación , Leptospira interrogans/genética , Leptospira interrogans/inmunología , Leptospirosis/complicaciones , Masculino , SerogrupoRESUMEN
Prophylactic antibiotics have been recommended in patients with a previous history of spontaneous bacterial peritonitis (SBP). Recently, there has been interest in the use of rifaximin for the prevention of SBP and hepatorenal syndrome (HRS). We conducted a meta-analysis to evaluate this association of rifaximin. We searched several databases from inception through 24 January 2017, to identify comparative studies evaluating the effect of rifaximin on the occurrence of SBP and HRS. We performed predetermined subgroup analyses based on the type of control group, design of the study, and type of prophylaxis. Pooled odds ratios (ORs) were calculated using a random effects model. We included 13 studies with 1703 patients in the meta-analysis of SBP prevention. Pooled OR [95% confidence interval (CI)] was 0.40 (95% CI: 0.22-0.73) (I=58%). On sensitivity analysis, adjusted OR was 0.29 (95% CI: 0.20-0.44) (I=0%). The results of the subgroup analysis based on type of control was as follows: in the quinolone group, pooled OR was 0.42 (95% CI: 0.14-1.25) (I=55%), and in the no antibiotic group, pooled OR was 0.40 (95% CI: 0.18-0.86) (I=64%). However, with sensitivity analysis, benefit of rifaximin was demonstrable; pooled ORs were 0.32 (95% CI: 0.17-0.63) (I=0%) and 0.28 (95% CI: 0.17-0.45) (I=0%) for the comparison with quinolones and no antibiotics, respectively. Pooled OR based on randomized controlled trials was 0.41 (95% CI: 0.22-0.75) (I=13%). For the prevention of HRS, the pooled OR was 0.25 (95% CI: 0.13-0.50) (I=0%). Rifaximin has a protective effect against the development of SBP in cirrhosis. However, the quality of the evidence as per the GRADE framework was very low. Rifaximin appeared effective for the prevention of HRS.
Asunto(s)
Antibacterianos/uso terapéutico , Infecciones Bacterianas/prevención & control , Síndrome Hepatorrenal/prevención & control , Cirrosis Hepática/tratamiento farmacológico , Peritonitis/prevención & control , Rifamicinas/uso terapéutico , Antibacterianos/efectos adversos , Infecciones Bacterianas/diagnóstico , Infecciones Bacterianas/microbiología , Distribución de Chi-Cuadrado , Femenino , Síndrome Hepatorrenal/diagnóstico , Síndrome Hepatorrenal/microbiología , Humanos , Cirrosis Hepática/complicaciones , Cirrosis Hepática/diagnóstico , Cirrosis Hepática/microbiología , Masculino , Oportunidad Relativa , Peritonitis/diagnóstico , Peritonitis/microbiología , Rifamicinas/efectos adversos , Rifaximina , Resultado del TratamientoRESUMEN
MircoRNA's (miR) have been recognised as important modulators of gene expression and potential biomarkers. However, they have been rarely investigated in bio fluids apart from blood. We investigated the association of miR-125b and miR-155 with complications of cirrhosis. Ascites was prospectively collected from patients with cirrhosis undergoing paracentesis at our department. miR's were determined in the supernatant using qPCR and normalized by SV-40. Clinical parameters were assessed at paracentesis and during follow-up. 76 specimens from 72 patients were analysed. MiR's were not associated to age, sex or aetiology of cirrhosis. MiR-125b levels differed between patients with low and high MELD score, and miR-125b levels showed an inverse correlation to serum creatinine (r2 = -0.23; p = 0.05). MiR-155 was elevated in patients with spontaneous bacterial peritonitis (SBP) (n = 10; p = 0.04). MiR-155 levels differed between patients with and without 30-day survival (p = 0.02). No association of ascites levels of investigated miR's to size of varices, episodes of gastrointestinal bleeding or hepatorenal syndrome was observed. While miR-125b levels in ascites seem to be associated with liver and renal dysfunction, miR-155 might be implicated in local immune response in SBP.
Asunto(s)
Ascitis/genética , Ascitis/microbiología , Infecciones Bacterianas/genética , Infecciones Bacterianas/microbiología , MicroARNs/genética , Peritonitis/genética , Peritonitis/microbiología , Regulación hacia Arriba/genética , Anciano , Ascitis/sangre , Ascitis/complicaciones , Infecciones Bacterianas/sangre , Infecciones Bacterianas/complicaciones , Biomarcadores/sangre , Estudios de Cohortes , Creatinina/sangre , Várices Esofágicas y Gástricas/sangre , Várices Esofágicas y Gástricas/complicaciones , Várices Esofágicas y Gástricas/genética , Várices Esofágicas y Gástricas/microbiología , Femenino , Síndrome Hepatorrenal/sangre , Síndrome Hepatorrenal/complicaciones , Síndrome Hepatorrenal/microbiología , Humanos , Inflamación/sangre , Inflamación/complicaciones , Inflamación/patología , Neoplasias Hepáticas/complicaciones , Neoplasias Hepáticas/patología , Masculino , MicroARNs/metabolismo , Persona de Mediana Edad , Peritonitis/sangre , Peritonitis/complicaciones , Análisis de SupervivenciaRESUMEN
Acute kidney injury (AKI) is a common and life-threatening complication in patients with cirrhosis. Recently, new criteria for the diagnosis of AKI have been proposed in patients with cirrhosis by the International Club of Ascites. Almost all types of bacterial infections can induce AKI in patients with cirrhosis representing its most common precipitating event. The bacterial infection-induced AKI usually meets the diagnostic criteria of hepatorenal syndrome (HRS). Well in keeping with the "splanchnic arterial vasodilation hypothesis", it has been stated that HRS develops as a consequence of a severe reduction of effective circulating volume related to splanchnic arterial vasodilation and to an inadequate cardiac output. Nevertheless, the role of bacterial infections in precipitating organ failures, including renal failure, is enhanced when their course is characterized by the development of a systemic inflammatory response syndrome (SIRS), thus, when sepsis occurs. Sepsis has been shown to be capable to induce "per se" AKI in animals as well as in patients conditioning also the features of renal damage. This observation suggests that when precipitated by sepsis, the pathogenesis and the clinical course of AKI also in patients with cirrhosis may differentiate to a certain extent from AKI with another or no precipitating factor. The purpose of this review is to describe the features of AKI precipitated by bacterial infections and to highlight whether infection and/or the development of SIRS may influence its clinical course, and, in particular, the response to treatment.
Asunto(s)
Lesión Renal Aguda/microbiología , Infecciones Bacterianas/complicaciones , Síndrome Hepatorrenal/microbiología , Cirrosis Hepática/microbiología , Sepsis/microbiología , Biomarcadores/análisis , Síndrome Hepatorrenal/terapia , HumanosRESUMEN
Spontaneous bacterial peritonitis (SBP) is an infection of patients with cirrhosis and ascites. This peculiarity is due to the frequent intestinal translocation that allows bacteria to cross the intestinal barrier, colonizing the ascitic fluid. In cirrhosis, SBP is inferior only to urinary tract infections. It is prevalently sustained by Gram-negative bacteria such as Escherichia coli and Klebsiella. Risk factors for developing SBP are advanced age, refractory ascites, variceal bleeding, renal failure, low albumin levels (below 2.5 g/ml), bilirubin over 4 mg/dl, Child-Pugh class C and a previous diagnosis of SBP. Thus, this is an indication for a long-term antibiotic prophylaxis with norfloxacin. Renal failure - especially the hepatorenal syndrome - complicates SBP in about 20% of cases independently of the efficacy of the antibiotic therapy. The mortality of these patients is about 90%. Infusion of albumin significantly reduces the incidence of hepatorenal syndrome and consequently the risk of death. Long-term quinolonic prophylaxis as well as increased antibiotic therapies are causing the emergence of multidrug-resistant agents as frequent causes of SBP. In such cases, the antibiotic sensitivity to quinolones is low, and European recommendations suggest a second-line antibiotic therapy, including meropenem or piperacillin plus tazobactam. Collection of blood, urine and ascitic fluid for cultures is important for bacterial recognition, possibly before starting an empirical antibiotic therapy. Indeed, the probability of positive cultures rapidly vanishes when they are performed during already implemented antibiotic administration. It is important to know that a failure of the first-line therapy is associated with an increased probability of death.
Asunto(s)
Antibacterianos/uso terapéutico , Ascitis/complicaciones , Infecciones por Bacterias Gramnegativas/tratamiento farmacológico , Cirrosis Hepática/complicaciones , Peritonitis/tratamiento farmacológico , Factores de Edad , Albúminas/uso terapéutico , Profilaxis Antibiótica/métodos , Bilirrubina/sangre , Resistencia a Múltiples Medicamentos , Quimioterapia Combinada , Várices Esofágicas y Gástricas , Hemorragia Gastrointestinal , Infecciones por Bacterias Gramnegativas/complicaciones , Infecciones por Bacterias Gramnegativas/microbiología , Síndrome Hepatorrenal/tratamiento farmacológico , Síndrome Hepatorrenal/microbiología , Síndrome Hepatorrenal/mortalidad , Humanos , Norfloxacino/uso terapéutico , Peritonitis/sangre , Peritonitis/microbiología , Factores de Riesgo , Albúmina Sérica/análisisRESUMEN
UNLABELLED: The major impact of sepsis-induced multiple organ dysfunction on healthcare system in the European Union was estimated at 90.4 cases per 100000 inhabitants, compared to 58 per 100000 for breast cancer. The association of organ dysfunctions in terms of both the number of dysfunctions and the degree of organ dysfunction is the most powerful predictor of death in sepsis. AIM: To find medical and statistical correlations in hepatorenal dysfunction in sepsis patients. MATERIAL AND METHODS: This retrospective study included 117 patients diagnosed with sepsis at the Iasi Infectious Diseases Hospital, patients who presented liver/renal and other organ dysfunctions. The clinical, etiological, and laboratory data, and APACHE II prognostic scores were analyzed. The data were processed using SPSS version 16.0. RESULTS: The etiological agents were Gram positive as well as Gram negative bacteria, and 40% of sepsis patients with hepatic/kidney dysfunction presented hepatorenal syndrome. CONCLUSIONS: Over one-third of patients with sepsis-related hepatorenal dysfunction had a creatinine clearance of less than 30 ml/min, and we found statistical correlations between serum creatinine and APACHE II score. There were no statistically significant differences between the survival curves of patients with hepatorenal syndrome and those with sepsis-related hepatorenal dysfunction.
Asunto(s)
Bacteriemia/diagnóstico , Síndrome Hepatorrenal/diagnóstico , Anciano , Anciano de 80 o más Años , Bacteriemia/complicaciones , Bacteriemia/epidemiología , Bacteriemia/microbiología , Bacteriemia/orina , Biomarcadores/orina , Creatinina/orina , Unión Europea/estadística & datos numéricos , Femenino , Síndrome Hepatorrenal/epidemiología , Síndrome Hepatorrenal/etiología , Síndrome Hepatorrenal/microbiología , Síndrome Hepatorrenal/orina , Humanos , Incidencia , Estimación de Kaplan-Meier , Pruebas de Función Renal , Pruebas de Función Hepática , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Retrospectivos , Rumanía/epidemiologíaRESUMEN
Leptospirosis is a re-emerging spirochetal zoonosis with a worldwide distribution affecting both animals and humans. The clinical syndromes may vary from a subclinical infection to a severe illness. Although it may potentially have a fulminant and fatal course, leptospirosis usually remains as an underdiagnosed cause of multiorgan failure. In this study, we report a patient with leptospirosis who presented with a fulminant course of diffuse alveolar haemorrhage and hepatorenal failure. His clinical condition deteriorated, despite appropriate antibiotic therapy and haemodialysis. However, he showed prompt clinical improvement when corticosteroids and plasma exchange were instituted in addition to the original therapy. We conclude that leptospirosis should be considered in any case presenting with pulmonary haemorrhage and hepatorenal failure. Plasma exchange and corticosteroids may be a choice of treatment in selected patients unresponsive to conventional therapy. Potential benefits of plasma exchange and corticosteroids may be based on a toxin- and/or cytokine-mediated pathogenesis of the disease.
Asunto(s)
Hemorragia/microbiología , Síndrome Hepatorrenal/microbiología , Leptospirosis , Enfermedades Pulmonares/microbiología , Adulto , Hemorragia/diagnóstico por imagen , Humanos , Enfermedades Pulmonares/diagnóstico por imagen , Masculino , RadiografíaRESUMEN
Darkground Microscopy (DGM) was initially done on Plasma in the Department of Microbiology, Kasturba Medical College, Manipal for 44 cases of suspected Leptospiral hepatorenal involvement. A total of 60 sera were collected from these patients and stored at -70 degrees C. Passiive haemagglutination test (PHA) was performed on 25 sera and latex agglutination test on 35 sera (Leptospira antigen Seiken) Leptospira was detected by Darkground Microscopy in 12 patients (27.27%). Serology was positive in 16 samples (36.36%) of which 7 (15.90%) by PHA and 9 by Latex agglutination (20.45%). Serological tests confirmed the findings of Darkground Microscopy. DGM was found to be simple and rapid and could be performed on all suspected patients.